Bednarski JJ, Sleckman BP. At the intersection of DNA damage and immune responses. Nat Rev Immunol. 2019;19:231–42.
Article CAS PubMed PubMed Central Google Scholar
Chen L, Flies DB. Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat Rev Immunol. 2013;13:227–42.
Article PubMed PubMed Central Google Scholar
Ruf B, Greten TF, Korangy F. Innate lymphoid cells and innate-like T cells in cancer - at the crossroads of innate and adaptive immunity. Nat Rev Cancer. 2023;23:351–71.
Article CAS PubMed Google Scholar
Kumar BV, Connors TJ, Farber DL. Human T cell development, localization, and function throughout life. Immunity. 2018;48:202–13.
Article CAS PubMed PubMed Central Google Scholar
Fragoso R, Ren D, Zhang X, Su MW, Burakoff SJ, Jin YJ. Lipid raft distribution of CD4 depends on its palmitoylation and association with Lck, and evidence for CD4-induced lipid raft aggregation as an additional mechanism to enhance CD3 signaling. J Immunol. 2003;170:913–21.
Article CAS PubMed Google Scholar
Zhang W, Trible RP, Samelson LE. LAT palmitoylation: its essential role in membrane microdomain targeting and tyrosine phosphorylation during T cell activation. Immunity. 1998;9:239–46.
Article CAS PubMed Google Scholar
Akimzhanov AM, Boehning D. Rapid and transient palmitoylation of the tyrosine kinase Lck mediates fas signaling. Proc Natl Acad Sci USA. 2015;112:11876–80.
Article CAS PubMed PubMed Central Google Scholar
Fredericks GJ, Hoffmann FW, Rose AH, Osterheld HJ, Hess FM, Mercier F, et al. Stable expression and function of the inositol 1,4,5-triphosphate receptor requires palmitoylation by a DHHC6/selenoprotein K complex. Proc Natl Acad Sci USA. 2014;111:16478–83.
Article CAS PubMed PubMed Central Google Scholar
Yao H, Lan J, Li C, Shi H, Brosseau JP, Wang H, et al. Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours. Nat Biomed Eng. 2019;3:306–17.
Article CAS PubMed Google Scholar
Yang Y, Hsu JM, Sun L, Chan LC, Li CW, Hsu JL, et al. Palmitoylation stabilizes PD-L1 to promote breast tumor growth. Cell Res. 2019;29:83–6.
Chen R, Ganesan A, Okoye I, Arutyunova E, Elahi S, Lemieux MJ, et al. Targeting B7-1 in immunotherapy. Med Res Rev. 2020;40:654–82.
Article CAS PubMed Google Scholar
Pulanco MC, Madsen AT, Tanwar A, Corrigan DT, Zang X. Recent advancements in the B7/CD28 immune checkpoint families: new biology and clinical therapeutic strategies. Cell Mol Immunol. 2023;20:694–713.
Article CAS PubMed Google Scholar
Nishimura CD, Pulanco MC, Cui W, Lu L, Zang X. PD-L1 and B7-1 cis-interaction: new mechanisms in immune checkpoints and immunotherapies. Trends Mol Med. 2021;27:207–19.
Article CAS PubMed Google Scholar
Ribas A, Wolchok JD. Cancer immunotherapy using checkpoint blockade. Science. 2018;359:1350–5.
Article CAS PubMed PubMed Central Google Scholar
Postow MA, Sidlow R, Hellmann MD. Immune-related adverse events associated with immune checkpoint blockade. N Engl J Med. 2018;378:158–68.
Article CAS PubMed Google Scholar
Ramos-Casals M, Brahmer JR, Callahan MK, Flores-Chavez A, Keegan N, Khamashta MA, et al. Immune-related adverse events of checkpoint inhibitors. Nat Rev Dis Prim. 2020;6:38.
Jiang H, Zhang X, Chen X, Aramsangtienchai P, Tong Z, Lin H. Protein lipidation: occurrence, mechanisms, biological functions, and enabling technologies. Chem Rev. 2018;118:919–88.
Article CAS PubMed PubMed Central Google Scholar
Chamberlain LH, Shipston MJ. The physiology of protein S-acylation. Physiol Rev. 2015;95:341–76.
Article CAS PubMed PubMed Central Google Scholar
Ko PJ, Dixon SJ. Protein palmitoylation and cancer. EMBO Rep. 2018;19:e46666.
Article PubMed PubMed Central Google Scholar
Lanyon-Hogg T, Faronato M, Serwa RA, Tate EW. Dynamic protein acylation: new substrates, mechanisms, and drug targets. Trends Biochem Sci. 2017;42:566–81.
Article CAS PubMed Google Scholar
Lu B, Chen XB, Hong YC, Zhu H, He QJ, Yang B, et al. Identification of PRDX6 as a regulator of ferroptosis. Acta Pharmacol Sin. 2019;40:1334–42.
Article PubMed PubMed Central Google Scholar
Yuan M, Chen X, Sun Y, Jiang L, Xia Z, Ye K, et al. Zdhhc12-mediated claudin-3 S-palmitoylation determines ovarian cancer progression. Acta Pharm Sin B. 2020;10:1426–39.
Article CAS PubMed PubMed Central Google Scholar
Cao J, Sun L, Aramsangtienchai P, Spiegelman NA, Zhang X, Huang W, et al. HDAC11 regulates type I interferon signaling through defatty-acylation of SHMT2. Proc Natl Acad Sci USA. 2019;116:5487–92.
Article CAS PubMed PubMed Central Google Scholar
Zhang Z, Li X, Yang F, Chen C, Liu P, Ren Y, et al. DHHC9-mediated glut1 S-palmitoylation promotes glioblastoma glycolysis and tumorigenesis. Nat Commun. 2021;12:5872.
Article CAS PubMed PubMed Central Google Scholar
Wang J, Hao JW, Wang X, Guo H, Sun HH, Lai XY, et al. DHHC4 and DHHC5 facilitate fatty acid uptake by palmitoylating and targeting CD36 to the plasma membrane. Cell Rep. 2019;26:209–21.
Mesquita FS, Abrami L, Sergeeva O, Turelli P, Qing E, Kunz B, et al. S-acylation controls SARS-cov-2 membrane lipid organization and enhances infectivity. Dev Cell. 2021;56:2790–807.
Article CAS PubMed PubMed Central Google Scholar
Mukai K, Konno H, Akiba T, Uemura T, Waguri S, Kobayashi T, et al. Activation of Sting requires palmitoylation at the Golgi. Nat Commun. 2016;7:11932.
Article CAS PubMed PubMed Central Google Scholar
Runkle KB, Kharbanda A, Stypulkowski E, Cao XJ, Wang W, Garcia BA, et al. Inhibition of DHHC20-mediated EGFR palmitoylation creates a dependence on EGFR signaling. Mol Cell. 2016;62:385–96.
Article CAS PubMed PubMed Central Google Scholar
Cao J, Chen X, Jiang L, Lu B, Yuan M, Zhu D, et al. DJ-1 suppresses ferroptosis through preserving the activity of S-adenosyl homocysteine hydrolase. Nat Commun. 2020;11:1251.
Article CAS PubMed PubMed Central Google Scholar
Lee CJ, Stix R, Rana MS, Shikwana F, Murphy RE, Ghirlando R, et al. Bivalent recognition of fatty acyl-CoA by a human integral membrane palmitoyltransferase. Proc Natl Acad Sci USA. 2022;119:e2022050119.
Article CAS PubMed PubMed Central Google Scholar
Lin H. Protein cysteine palmitoylation in immunity and inflammation. FEBS J. 2021;288:7043–59.
Article CAS PubMed PubMed Central Google Scholar
Du W, Hua F, Li X, Zhang J, Li S, Wang W, et al. Loss of optineurin drives cancer immune evasion via palmitoylation-dependent IFNGR1 lysosomal sorting and degradation. Cancer Discov. 2021;11:1826–43.
Article CAS PubMed PubMed Central Google Scholar
Piper RC, Luzio JP. Ubiquitin-dependent sorting of integral membrane proteins for degradation in lysosomes. Curr Opin Cell Biol. 2007;19:459–65.
Article CAS PubMed PubMed Central Google Scholar
Hegde RS, Keenan RJ. The mechanisms of integral membrane protein biogenesis. Nat Rev Mol Cell Biol. 2022;23:107–24.
Article CAS PubMed Google Scholar
Braun M, Aguilera AR, Sundarrajan A, Corvino D, Stannard K, Krumeich S, et al. CD155 on tumor cells drives resistance to immunotherapy by inducing the degradation of the activating receptor CD226 in CD8+ T cells. Immunity. 2020;53:805–23.
留言 (0)